Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children's Oncology Group Studies P9904 and P9905.

Winick N, Martin PL, Devidas M, Shuster J, Borowitz MJ, Paul Bowman W, Larsen E, Pullen J, Carroll A, Willman C, Hunger SP, Carroll WL, Camitta BM.

Leukemia. 2019 Nov 14. doi: 10.1038/s41375-019-0642-2. [Epub ahead of print]

PMID:
31728054
2.

Sharing the results of a patient satisfaction audit.

Walker K, Watkins R, Newman S, Pullen J, Osborne D, Milton S, Davies T.

Br J Nurs. 2018 Mar 8;27(5):S4-S14. doi: 10.12968/bjon.2018.27.5.S4.

PMID:
29517332
3.

Workshop report: Nucleic acid delivery devices for HIV vaccines: Workshop proceedings, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, May 21, 2015.

Weniger BG, Anglin IE, Tong T, Pensiero M, Pullen JK; Nucleic Acid Delivery Devices for HIV Vaccines Workshop Group.

Vaccine. 2018 Jan 25;36(4):427-437. doi: 10.1016/j.vaccine.2017.10.071. Epub 2017 Nov 22.

PMID:
29174315
4.

Peripheral synucleinopathy in early Parkinson's disease: Submandibular gland needle biopsy findings.

Adler CH, Dugger BN, Hentz JG, Hinni ML, Lott DG, Driver-Dunckley E, Mehta S, Serrano G, Sue LI, Duffy A, Intorcia A, Filon J, Pullen J, Walker DG, Beach TG.

Mov Disord. 2017 May;32(5):722-723. doi: 10.1002/mds.27044. No abstract available.

PMID:
28513078
5.

Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings.

Adler CH, Dugger BN, Hentz JG, Hinni ML, Lott DG, Driver-Dunckley E, Mehta S, Serrano G, Sue LI, Duffy A, Intorcia A, Filon J, Pullen J, Walker DG, Beach TG.

Mov Disord. 2016 Feb;31(2):250-6. doi: 10.1002/mds.26476. Epub 2016 Jan 22.

6.

Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404.

Asselin BL, Devidas M, Chen L, Franco VI, Pullen J, Borowitz MJ, Hutchison RE, Ravindranath Y, Armenian SH, Camitta BM, Lipshultz SE.

J Clin Oncol. 2016 Mar 10;34(8):854-62. doi: 10.1200/JCO.2015.60.8851. Epub 2015 Dec 23. Erratum in: J Clin Oncol. 2017 Jun 20;35(18):2100.

7.

A descriptive study of baccalaureate nursing students' responses to suicide prevention education.

Pullen JM, Gilje F, Tesar E.

Nurse Educ Pract. 2016 Jan;16(1):104-10. doi: 10.1016/j.nepr.2015.09.007. Epub 2015 Oct 9.

PMID:
26494302
8.

Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases.

Serrano GE, Intorcia A, Carew J, Chiarolanza G, Hidalgo JA, Sue LI, Dugger BN, Saxon-LaBelle M, Filon J, Scroggins A, Pullen J, Fornwalt BE, Scott S, Sabbagh MN, Adler CH, Akiyama H, Beach TG.

J Neuropathol Exp Neurol. 2015 Sep;74(9):934-42. doi: 10.1097/NEN.0000000000000235.

9.

Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia.

Sitthi-Amorn J, Herrington B, Megason G, Pullen J, Gordon C, Hogan S, Koganti T, Hicks C.

Clin Med Insights Oncol. 2015 May 24;9:51-60. doi: 10.4137/CMO.S17049. eCollection 2015.

10.

Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: what are the "cGMP"?

Sheets RL, Rangavajhula V, Pullen JK, Butler C, Mehra V, Shapiro S, Pensiero M.

Vaccine. 2015 Apr 8;33(15):1757-66. doi: 10.1016/j.vaccine.2015.02.003. Epub 2015 Feb 16. Review.

11.

New York City Panel on Climate Change 2015 Report. Chapter 5: Public health impacts and resiliency.

Kinney PL, Matte T, Knowlton K, Madrigano J, Petkova E, Weinberger K, Quinn A, Arend M, Pullen J.

Ann N Y Acad Sci. 2015 Jan;1336:67-88. doi: 10.1111/nyas.12588. No abstract available.

12.

Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG, Lue L, Roher AE, Dugger BN, Maarouf C, Birdsill AC, Intorcia A, Saxon-Labelle M, Pullen J, Scroggins A, Filon J, Scott S, Hoffman B, Garcia A, Caviness JN, Hentz JG, Driver-Dunckley E, Jacobson SA, Davis KJ, Belden CM, Long KE, Malek-Ahmadi M, Powell JJ, Gale LD, Nicholson LR, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Burke AD, Reiman EM, Sabbagh MN.

Neuropathology. 2015 Aug;35(4):354-89. doi: 10.1111/neup.12189. Epub 2015 Jan 26.

13.

Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).

Dreyer ZE, Hilden JM, Jones TL, Devidas M, Winick NJ, Willman CL, Harvey RC, Chen IM, Behm FG, Pullen J, Wood BL, Carroll AJ, Heerema NA, Felix CA, Robinson B, Reaman GH, Salzer WL, Hunger SP, Carroll WL, Camitta BM.

Pediatr Blood Cancer. 2015 Mar;62(3):419-26. doi: 10.1002/pbc.25322. Epub 2014 Nov 14.

14.

Placental alpha-microglobulin-1 and combined traditional diagnostic test: a cost-benefit analysis.

Echebiri NC, McDoom MM, Pullen JA, Aalto MM, Patel NN, Doyle NM.

Am J Obstet Gynecol. 2015 Jan;212(1):77.e1-10. doi: 10.1016/j.ajog.2014.07.028. Epub 2014 Jul 22.

PMID:
25063741
15.

Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.

Tower RL, Jones TL, Camitta BM, Asselin BL, Bell BA, Chauvenet A, Devidas M, Halperin EC, Pullen J, Shuster JJ, Winick N, Kurtzberg J.

J Pediatr Hematol Oncol. 2014 Jul;36(5):353-61. doi: 10.1097/MPH.0000000000000131.

16.

Ligand-induced activation of a formin-NPF pair leads to collaborative actin nucleation.

Graziano BR, Jonasson EM, Pullen JG, Gould CJ, Goode BL.

J Cell Biol. 2013 May 13;201(4):595-611. doi: 10.1083/jcb.201212059.

17.

Assessing the preferred solution conformation of an interacting sense-antisense (complementary) peptide pair.

Pullen JR, Dalmaris J, Serapian SA, Miller AD.

Bioorg Med Chem Lett. 2013 Jan 15;23(2):496-502. doi: 10.1016/j.bmcl.2012.11.038. Epub 2012 Nov 21.

PMID:
23245517
18.

Escherichia coli LysU is a potential surrogate for human lysyl tRNA synthetase in interactions with the C-terminal domain of HIV-1 capsid protein.

Boonyalai N, Pullen JR, Abdul Wahab MF, Wright M, Miller AD.

Org Biomol Chem. 2013 Jan 28;11(4):612-20. doi: 10.1039/c2ob26499d. Epub 2012 Dec 4.

PMID:
23208549
19.

Striving for excellence: developing a framework for the Triple C curriculum in family medicine education.

MacDonald CJ, McKeen M, Wooltorton E, Boucher F, Lemelin J, Leith-Gudbranson D, Viner G, Pullen J.

Can Fam Physician. 2012 Oct;58(10):e555-62.

20.

Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404).

Asselin BL, Devidas M, Wang C, Pullen J, Borowitz MJ, Hutchison R, Lipshultz SE, Camitta BM.

Blood. 2011 Jul 28;118(4):874-83. doi: 10.1182/blood-2010-06-292615. Epub 2011 Apr 7.

21.

Highly sensitive and selective "turn-on" calcium cation sensing from a dendronic terthiophene tetraethylene glycol (TEG) molecule.

Park Y, Apodaca DC, Pullen J, Advincula RC.

J Phys Chem B. 2010 Oct 21;114(41):13084-94. doi: 10.1021/jp1068522.

PMID:
20873811
22.

The effect of pilot balloon design on estimation of safe tracheal tube cuff pressure.

Janossy KM, Pullen J, Young D, Bell G.

Anaesthesia. 2010 Aug;65(8):785-91. doi: 10.1111/j.1365-2044.2010.06413.x. Epub 2010 Jun 22.

23.

Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group.

Maloney KW, Carroll WL, Carroll AJ, Devidas M, Borowitz MJ, Martin PL, Pullen J, Whitlock JA, Willman CL, Winick NJ, Camitta BM, Hunger SP.

Blood. 2010 Aug 19;116(7):1045-50. doi: 10.1182/blood-2009-07-235291. Epub 2010 May 4.

24.

Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group.

Salzer WL, Devidas M, Carroll WL, Winick N, Pullen J, Hunger SP, Camitta BA.

Leukemia. 2010 Feb;24(2):355-70. doi: 10.1038/leu.2009.261. Epub 2009 Dec 17.

25.

The discovery and optimisation of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase.

Malagu K, Duggan H, Menear K, Hummersone M, Gomez S, Bailey C, Edwards P, Drzewiecki J, Leroux F, Quesada MJ, Hermann G, Maine S, Molyneaux CA, Le Gall A, Pullen J, Hickson I, Smith L, Maguire S, Martin N, Smith G, Pass M.

Bioorg Med Chem Lett. 2009 Oct 15;19(20):5950-3. doi: 10.1016/j.bmcl.2009.08.038. Epub 2009 Aug 13.

PMID:
19762236
26.

Identification of a mechanical rheostat in the hydrophobic core of protein L.

Sadler DP, Petrik E, Taniguchi Y, Pullen JR, Kawakami M, Radford SE, Brockwell DJ.

J Mol Biol. 2009 Oct 16;393(1):237-48. doi: 10.1016/j.jmb.2009.08.015. Epub 2009 Aug 13.

27.

Effectiveness of psychoanalytic psychotherapy for adolescents with serious mental illness: 12 month naturalistic follow-up study.

Tonge BJ, Pullen JM, Hughes GC, Beaufoy J.

Aust N Z J Psychiatry. 2009 May;43(5):467-75. doi: 10.1080/00048670902817679.

PMID:
19373709
28.

Mirror therapy promotes recovery from severe hemiparesis: a randomized controlled trial.

Dohle C, Püllen J, Nakaten A, Küst J, Rietz C, Karbe H.

Neurorehabil Neural Repair. 2009 Mar-Apr;23(3):209-17. doi: 10.1177/1545968308324786. Epub 2008 Dec 12.

PMID:
19074686
29.

Comprehensive description of adolescents admitted to a public psychiatric inpatient unit and their families.

Tonge BJ, Hughes GC, Pullen JM, Beaufoy J, Gold S.

Aust N Z J Psychiatry. 2008 Jul;42(7):627-35. doi: 10.1080/00048670802119770.

PMID:
18612866
30.

Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.

Rubnitz JE, Wichlan D, Devidas M, Shuster J, Linda SB, Kurtzberg J, Bell B, Hunger SP, Chauvenet A, Pui CH, Camitta B, Pullen J; Children's Oncology Group.

J Clin Oncol. 2008 May 1;26(13):2186-91. doi: 10.1200/JCO.2007.14.3552.

31.

Religiosity and coping in mothers of children diagnosed with cancer: an exploratory analysis.

Elkin TD, Jensen SA, McNeil L, Gilbert ME, Pullen J, McComb L.

J Pediatr Oncol Nurs. 2007 Sep-Oct;24(5):274-8.

PMID:
17827493
32.

Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study.

Wacker P, Land VJ, Camitta BM, Kurtzberg J, Pullen J, Harris MB, Shuster JJ; Children's Oncology Study Group.

J Pediatr Hematol Oncol. 2007 Sep;29(9):627-32.

PMID:
17805038
33.

LPIN2 is associated with type 2 diabetes, glucose metabolism, and body composition.

Aulchenko YS, Pullen J, Kloosterman WP, Yazdanpanah M, Hofman A, Vaessen N, Snijders PJ, Zubakov D, Mackay I, Olavesen M, Sidhu B, Smith VE, Carey A, Berezikov E, Uitterlinden AG, Plasterk RH, Oostra BA, van Duijn CM.

Diabetes. 2007 Dec;56(12):3020-6. Epub 2007 Sep 5.

34.

Microanalysis of amoxicillin, flucloxacillin, and rifampicin in neonatal plasma.

Pullen J, Stolk LM, Neef C, Zimmermann LJ.

Biomed Chromatogr. 2007 Dec;21(12):1259-65.

PMID:
17604357
35.

Amoxicillin pharmacokinetics in (preterm) infants aged 10 to 52 days: effect of postnatal age.

Pullen J, Driessen M, Stolk LM, Degraeuwe PL, van Tiel FH, Neef C, Zimmermann LJ.

Ther Drug Monit. 2007 Jun;29(3):376-80.

PMID:
17529898
36.

Protein binding of flucloxacillin in neonates.

Pullen J, Stolk LM, Degraeuwe PL, van Tiel FH, Neef C, Zimmermann LJ.

Ther Drug Monit. 2007 Jun;29(3):279-83.

PMID:
17529883
37.

Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.

Chauvenet AR, Martin PL, Devidas M, Linda SB, Bell BA, Kurtzberg J, Pullen J, Pettenati MJ, Carroll AJ, Shuster JJ, Camitta B.

Blood. 2007 Aug 15;110(4):1105-11. Epub 2007 Apr 18.

38.

Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia.

Heerema NA, Raimondi SC, Anderson JR, Biegel J, Camitta BM, Cooley LD, Gaynon PS, Hirsch B, Magenis RE, McGavran L, Patil S, Pettenati MJ, Pullen J, Rao K, Roulston D, Schneider NR, Shuster JJ, Sanger W, Sutcliffe MJ, van Tuinen P, Watson MS, Carroll AJ.

Genes Chromosomes Cancer. 2007 Jul;46(7):684-93.

39.

Pharmacokinetics of intravenous rifampicin (rifampin) in neonates.

Pullen J, Stolk LM, Degraeuwe PL, van Tiel FH, Neef C, Zimmermann LJ.

Ther Drug Monit. 2006 Oct;28(5):654-61.

PMID:
17038881
40.

Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.

Barredo JC, Devidas M, Lauer SJ, Billett A, Marymont M, Pullen J, Camitta B, Winick N, Carroll W, Ritchey AK.

J Clin Oncol. 2006 Jul 1;24(19):3142-9.

PMID:
16809737
41.

Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Mehta PA, Davies SM, Kumar A, Devidas M, Lee S, Zamzow T, Elliott J, Villanueva J, Pullen J, Zewge Y, Filipovich A; Children's Oncology Group.

Leukemia. 2006 Sep;20(9):1539-41. Epub 2006 Jun 22.

42.

Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates.

Pullen J, de Rozario L, Stolk LM, Degraeuwe PL, van Tiel FH, Zimmermann LJ.

Ther Drug Monit. 2006 Jun;28(3):351-8.

PMID:
16778719
43.

Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates.

Pullen J, Stolk LM, Nieman FH, Degraeuwe PL, van Tiel FH, Zimmermann LJ.

Ther Drug Monit. 2006 Apr;28(2):226-31.

PMID:
16628135
44.

Phase I trial of irofulven (MGI 114) in pediatric patients with solid tumors.

Bomgaars LR, Megason GC, Pullen J, Langevin AM, Dale Weitman S, Hershon L, Kuhn JG, Bernstein M, Blaney SM.

Pediatr Blood Cancer. 2006 Aug;47(2):163-8.

PMID:
16317728
45.

Factor analysis of the Pediatric Symptom Checklist with a chronically ill pediatric population.

Stoppelbein L, Greening L, Jordan SS, Elkin TD, Moll G, Pullen J.

J Dev Behav Pediatr. 2005 Oct;26(5):349-55.

PMID:
16222174
46.

Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.

Powell BS, Andrews GP, Enama JT, Jendrek S, Bolt C, Worsham P, Pullen JK, Ribot W, Hines H, Smith L, Heath DG, Adamovicz JJ.

Biotechnol Prog. 2005 Sep-Oct;21(5):1490-510.

PMID:
16209555
47.

Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia.

Savaşan S, Buck S, Ozdemir O, Hamre M, Asselin B, Pullen J, Ravindranath Y.

Leuk Lymphoma. 2005 Jun;46(6):833-40.

PMID:
16019527
49.

3-amino thioacridone inhibits DNA synthesis and induce DNA damage in T-cell acute lymphoblastic leukemia (T-ALL) in a p16-dependent manner.

Diccianni MB, Yu J, Meppelink G, de Vries M, Shao L, Gebauer S, Shih H, Roberts W, Kilcoin NP, Pullen J, Carson DA, Yu AL.

J Exp Ther Oncol. 2004 Oct;4(3):223-37.

50.

Linkage disequilibrium in young genetically isolated Dutch population.

Aulchenko YS, Heutink P, Mackay I, Bertoli-Avella AM, Pullen J, Vaessen N, Rademaker TA, Sandkuijl LA, Cardon L, Oostra B, van Duijn CM.

Eur J Hum Genet. 2004 Jul;12(7):527-34.

Supplemental Content

Loading ...
Support Center